130 related articles for article (PubMed ID: 35136872)
1. Awareness and Support of Clinician- and Patient-Collected Human Papillomavirus Testing for Cervical Cancer Screening Among Primary Care Clinicians.
MacLaughlin KL; Jacobson RM; St Sauver JL; Jenkins GD; Fan C; Finney Rutten LJ
Womens Health Rep (New Rochelle); 2022; 3(1):10-19. PubMed ID: 35136872
[No Abstract] [Full Text] [Related]
2. Primary human papillomavirus testing by clinician- versus self-collection: Awareness and acceptance among cervical cancer screening-eligible women.
MacLaughlin KL; Jenkins GD; St Sauver J; Fan C; Miller NE; Meyer AF; Jacobson RM; Finney Rutten LJ
J Med Screen; 2024 Jun; ():9691413241260019. PubMed ID: 38869176
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk-based management consensus guidelines.
Vadaparampil ST; Fuzzell LN; Brownstein NC; Fontenot HB; Lake P; Michel A; McIntyre M; Whitmer A; Perkins RB
Cancer; 2023 Sep; 129(17):2671-2684. PubMed ID: 37221653
[TBL] [Abstract][Full Text] [Related]
4. Clinician and Patient Acceptability of Self-Collected Human Papillomavirus Testing for Cervical Cancer Screening.
Mao C; Kulasingam SL; Whitham HK; Hawes SE; Lin J; Kiviat NB
J Womens Health (Larchmt); 2017 Jun; 26(6):609-615. PubMed ID: 28332888
[TBL] [Abstract][Full Text] [Related]
5. Clinician practices, knowledge, and attitudes regarding primary human papillomavirus testing for cervical cancer screening: A mixed-methods study in Indiana.
Rodriguez NM; Brennan LP; Claure L; Balian LN; Kasting ML; Champion VL; Forman MR
Prev Med Rep; 2023 Feb; 31():102070. PubMed ID: 36471770
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis.
Arbyn M; Verdoodt F; Snijders PJ; Verhoef VM; Suonio E; Dillner L; Minozzi S; Bellisario C; Banzi R; Zhao FH; Hillemanns P; Anttila A
Lancet Oncol; 2014 Feb; 15(2):172-83. PubMed ID: 24433684
[TBL] [Abstract][Full Text] [Related]
7. Uptake and correlates of cervical cancer screening among women attending a community-based multi-disease health campaign in Kenya.
Choi Y; Ibrahim S; Park LP; Cohen CR; Bukusi EA; Huchko MJ
BMC Womens Health; 2022 Apr; 22(1):122. PubMed ID: 35436908
[TBL] [Abstract][Full Text] [Related]
8. Programmatic human papillomavirus testing in cervical cancer prevention in the Jujuy Demonstration Project in Argentina: a population-based, before-and-after retrospective cohort study.
Arrossi S; Paolino M; Laudi R; Gago J; Campanera A; Marín O; Falcón C; Serra V; Herrero R; Thouyaret L
Lancet Glob Health; 2019 Jun; 7(6):e772-e783. PubMed ID: 31097279
[TBL] [Abstract][Full Text] [Related]
9. Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program.
Smith LW; Khurshed F; van Niekerk DJ; Krajden M; Greene SB; Hobbs S; Coldman AJ; Franco EL; Ogilvie GS
BMC Public Health; 2014 Oct; 14():1060. PubMed ID: 25303975
[TBL] [Abstract][Full Text] [Related]
10. Acceptability and Concordance of Self- Versus Clinician- Sampling for HPV Testing among Rural South Indian Women.
Madhivanan P; Nishimura H; Ravi K; Pope B; Coudray M; Arun A; Krupp K; Jayakrishna P; Srinivas V
Asian Pac J Cancer Prev; 2021 Mar; 22(3):971-976. PubMed ID: 33773563
[TBL] [Abstract][Full Text] [Related]
11. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis.
Arbyn M; Simon M; de Sanjosé S; Clarke MA; Poljak M; Rezhake R; Berkhof J; Nyaga V; Gultekin M; Canfell K; Wentzensen N
Lancet Oncol; 2022 Jul; 23(7):950-960. PubMed ID: 35709810
[TBL] [Abstract][Full Text] [Related]
12. Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial.
Polman NJ; Ebisch RMF; Heideman DAM; Melchers WJG; Bekkers RLM; Molijn AC; Meijer CJLM; Quint WGV; Snijders PJF; Massuger LFAG; van Kemenade FJ; Berkhof J
Lancet Oncol; 2019 Feb; 20(2):229-238. PubMed ID: 30658933
[TBL] [Abstract][Full Text] [Related]
13. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
14. Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial.
Winer RL; Lin J; Tiro JA; Miglioretti DL; Beatty T; Gao H; Kimbel K; Thayer C; Buist DSM
JAMA Netw Open; 2019 Nov; 2(11):e1914729. PubMed ID: 31693128
[TBL] [Abstract][Full Text] [Related]
15. Are Health Care Professionals Prepared to Implement Human Papillomavirus Testing? A Review of Psychosocial Determinants of Human Papillomavirus Test Acceptability in Primary Cervical Cancer Screening.
Tatar O; Wade K; McBride E; Thompson E; Head KJ; Perez S; Shapiro GK; Waller J; Zimet G; Rosberger Z
J Womens Health (Larchmt); 2020 Mar; 29(3):390-405. PubMed ID: 31479381
[No Abstract] [Full Text] [Related]
16. Primary HPV testing: U.S. women's awareness and acceptance of an emerging screening modality.
Saraiya M; Kwan A; Cooper CP
Prev Med; 2018 Mar; 108():111-114. PubMed ID: 29277414
[TBL] [Abstract][Full Text] [Related]
17. Comparison of detection rate of high risk HPV infection between self-collected HPV testing and clinician-collected HPV testing in cervical cancer screening.
Nutthachote P; Oranratanaphan S; Termrungruanglert W; Triratanachat S; Chaiwongkot A; Baedyananda F; Bhattarakosol P
Taiwan J Obstet Gynecol; 2019 Jul; 58(4):477-481. PubMed ID: 31307736
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis between self-collected and clinician-collected samples for HPV testing in public health facilities in Zimbabwe.
Joseph J; Mangwendeza P; Maparo T; Mhizha T; Demke O; Murwira S; Dickson H; Madzima B; Khan S
J Clin Virol; 2021 Dec; 145():105017. PubMed ID: 34715579
[TBL] [Abstract][Full Text] [Related]
20. Patient and clinician factors associated with uptake of the human papillomavirus (HPV) vaccine among adolescent patients of a primary care network.
Dang JHT; Stewart SL; Blumberg DA; Rodriguez HP; Chen MS
Vaccine; 2021 Jun; 39(26):3528-3535. PubMed ID: 34023133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]